Old Web
English
Sign In
Acemap
>
Paper
>
DYRK1A as a biomarker and a therapeutic target for cognitive deficits in Down syndrome and Alzheimer’s disease
DYRK1A as a biomarker and a therapeutic target for cognitive deficits in Down syndrome and Alzheimer’s disease
2016
Jean-Maurice Delabar
Nathalie Janel
Anne Badel
Jean-Louis Paul
A.S. Rebillat
Pinar Coskun
Jorge Busciglio
Ira T. Lott
M. Schubert
Marie Sarazin
P. Alexopoulos
Keywords:
Clinical psychology
Psychiatry
Psychology
Down syndrome
Disease
Biomarker (medicine)
Cognition
DYRK1A
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]